To further explore the clinical relevance of CK2-NCoR signaling and prostate cancer development, NCoR phosphorylation and IP-10 expression were evaluated by immunohistochemistry using tissue microarrays. This evidence concerns the gene CXCL10 and Familial prostate cancer.